학술논문

Impact of denosumab (DMB) compared with zoledronic acid (ZA) on renal function in the treatment of myeloma bone disease.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2017, 35 6p. Supplement: 15
Subject
Language
English
ISSN
15277755